Influence of a probiotic mixture on antibiotic induced microbiota disturbances

World Journal of Gastroenterology

Volumn 20, Issue 33, 2014, Pages 11878-11885

  Forssten, Sofia ^a   Evans, Malkanthi ^b   Wilson, Dale ^b   Ouwehand, Arthur C ^a  

^a DUPONT COMPANY   (United States)

^b KGK Synergize   (Canada)

Author keywords

Amoxicillin clavulanate; Antibiotic treatment; Beta lactamases; Bifidobacterium lactis; Lactobacillus acidophilus; Microbiota; Probiotic

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; EXTENDED SPECTRUM BETA LACTAMASE; PLACEBO; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BLOATING; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; DRUG WITHDRAWAL; ENTEROBACTERIACEAE; FECES MICROFLORA; FEMALE; FLATULENCE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINAL DYSMOTILITY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LOOSE FECES; MALE; MEDICATION COMPLIANCE; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH PAIN; DRUG EFFECTS; FECES; GROWTH, DEVELOPMENT AND AGING; INTESTINE; MICROBIOLOGY; MICROFLORA; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BIFIDOBACTERIUM; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; INTESTINES; LACTOBACILLUS ACIDOPHILUS; MALE; MEDICATION ADHERENCE; MICROBIOTA; PROBIOTICS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84909606380     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i33.11878     Document Type: Article

References (20)

1. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, Neulinger SC, Däumer C, Heinsen FA, Latorre A, Barbas C, Seifert J, dos Santos VM, Ott SJ, Ferrer M, Moya A. Gut microbiota disturbance during antibiotic therapy: a multiomic approach. Gut 2013; 62 : 1591-1601 [PMID: 23236009 DOI: 10.1136/gutjnl-2012-303184]
2. Food and Agriculture Organization/World Health Organization. Guidelines for the evaluation of probiotics in food 2002. Available from: URL: http://www.who.int/foodsafety/publications/fs-management/probiotics2/en/1-11
3. Corr SC, Hill C, Gahan CG. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res 2009; 56: 1-15 [PMID: 19389605 DOI: 10.1016/ S1043-4526(08)00601-3]
4. Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G, Kitts CL. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 2009; 58 : 663-670 [PMID: 19369530 DOI: 10.1099/jmm.0.47615-0]
5. Hempel S , Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307: 1959-1969 [PMID: 22570464 DOI: 10.1001/jama.2012.3507]
6. Lahtinen SJ, Forssten S, Aakko J, Granlund L, Rautonen N, Salminen S, Viitanen M, Ouwehand AC. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age (Dordr) 2012; 34 : 133-143 [PMID: 21264685 DOI: 10.1007/s11357-011-9208-6]
7. Ouwehand AC, ten Bruggencate SJ, Schonewille AJ, Alhoniemi E, Forssten SD, Bovee-Oudenhoven IM. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. Br J Nutr 2014; 111: 465-473 [PMID: 23930950 DOI: 10.1017/S0007114513002547]
8. Mäkivuokko H, Nurmi J, Nurminen P, Stowell J, Rautonen N. In vitro effects on polydextrose by colonic bacteria and caco-2 cell cyclooxygenase gene expression. Nutr Cancer 2005; 52: 94-104 [PMID: 16091009]
9. Mäkeläinen H , Forssten S, Saarinen M, Stowell J, Rautonen N, Ouwehand AC. Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Benef Microbes 2010; 1: 81-91 [PMID: 21831753]
10. Ventura M, Reniero R, Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 2001; 67: 2760-2765 [PMID: 11375192]
11. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004; 97: 1166-1177 [PMID: 15546407]
12. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004; 70: 6459-6465 [PMID: 15528506]
13. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNAtargeted reverse transcription-PCR. Appl Environ Microbiol 2007; 73: 32-39 [PMID: 17071791]
14. Apajalahti JH, Kettunen H, Kettunen A, Holben WE, Nurminen PH, Rautonen N, Mutanen M. Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Environ Microbiol 2002; 68: 4986-4995 [PMID: 12324348]
15. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30 : 1046-1052 [PMID: 8578162 DOI: 10.3109/00365529509101605]
16. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996; 221: 8-13 [PMID: 9110389 DOI: 10.3109/00365529609095544]
17. Koh H, Lee MJ, Kim MJ, Shin JI, Chung KS. Simple diagnostic approach to childhood fecal retention using the Leech score and Bristol stool form scale in medical practice. J Gastroenterol Hepatol 2010; 25: 334-338 [PMID: 19817956 DOI: 10.1111/j.1440-1746.2009.06015.x]
18. Plummer SF , Garaiova I, Sarvotham T, Cottrell SL, Le Scouiller S, Weaver MA, Tang J, Dee P, Hunter J. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents 2005; 26: 69-74 [PMID: 15967639]
19. Jernberg C , Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156: 3216-3223 [PMID: 20705661 DOI: 10.1099/mic.0.040618-0]
20. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamaseproducing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682-690 [PMID: 19622043]